Provider Resources WA

12/27/22 Health Advisory: Updated bivalent COVID-19 boosters authorized for children 6 months to 5 years old

| December 23, 2022
Individual with stethoscope and young child on exam table

Earlier this month, U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) expanded emergency use authorization (EUA) of Moderna and Pfizer-BioNTech bivalent vaccines for children 6 months and older. Updated (bivalent) COVID-19 booster vaccines are formulated to boost immunity against the original coronavirus strain and protect against the newer omicron … 12/27/22 Health Advisory: Updated bivalent COVID-19 boosters authorized for children 6 months to 5 years old

12/12/22 Health Advisory: COVID-19 Therapeutics Updates

| December 12, 2022
Syringe in vial

Bebtelovimab no longer authorized in the United States. On Nov. 30, 2022, U.S. Food and Drug Administration (FDA) revoked its Emergency Use Authorization (EUA) for bebtelovimab. Bebtelovimab is a monoclonal antibody used to treat COVID-19. FDA revoked the EUA because the drug lost efficacy against most SARS-CoV-2 variants currently circulating in the United States. Currently, … 12/12/22 Health Advisory: COVID-19 Therapeutics Updates

11/10/22 Health Advisory: Increased Respiratory Virus Activity

| November 10, 2022
Child in adult's arms while provider listens to their lungs

Multiple viruses are causing increased respiratory illness, especially among children, straining healthcare systems. Transmission of respiratory illnesses is increased in our communities. Schools report much higher absenteeism than normal for this time of year. Our hospital emergency departments are seeing many patients. This increase in illness early in respiratory illness season highlights the importance of … 11/10/22 Health Advisory: Increased Respiratory Virus Activity

10/31/22 Health Advisory: Updated bivalent COVID-19 boosters available to children 5 years or older

| October 19, 2022
Eight kids laying in a circle looking up at camera

Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA) and Western States Scientific Safety Review Workgroup approved an age expansion for updated bivalent COVID-19 vaccine booster doses. The expansion allows children: 5–11 years old to get 1 booster dose of Pfizer pediatric updated bivalent COVID-19 vaccine. 6–17 years old to get 1 … 10/31/22 Health Advisory: Updated bivalent COVID-19 boosters available to children 5 years or older

10/06/22 Health Advisory: Severe cases of monkeypox among people with immune compromise

| October 6, 2022
Warning yellow triangle with black exclamation point on left. "Health Advisory" on right.

Since May 2022, the United States has seen more than 25,000 cases of monkeypox virus (MPV). Most cases are mild to moderate, but some people are at higher risk of severe illness: Under 8 years old. Immune compromise. Atopic dermatitis or eczema. Pregnant. Unsuppressed or uncontrolled human immunodeficiency virus (HIV). Of those currently diagnosed with MPV … 10/06/22 Health Advisory: Severe cases of monkeypox among people with immune compromise

07/26/22 Health Advisory: Monkeypox Update

| July 27, 2022
Four doctors talking as seen from above. Two with white coats and 2 in scrubs.

We continue to monitor the monkeypox outbreak in Washington and the United States. Report possible monkeypox cases immediately upon suspicion, as Washington State Department of Health (DOH) requires. Call . We will help you complete an intake form and review exposure guidelines to evaluate close contacts. Monkeypox is rare and not often seen in the United States. It can cause a rash … 07/26/22 Health Advisory: Monkeypox Update

07/14/22 Health Advisory: Updated Monkeypox Guidance

| July 14, 2022
Exam room with vitals equipment on wall

Requested actions Washington currently has 16 reported cases of monkeypox, mostly in King County. Early cases were linked to travel but Public Health Seattle–King County announced last week the virus is likely spreading locally.  Monkeypox is rare and not often seen in the United States. It can cause a rash that looks like bumps, blisters … 07/14/22 Health Advisory: Updated Monkeypox Guidance

06/24/22 Health Advisory: Updated Monkeypox Guidance

| June 23, 2022
Scientists in lab using microscope

Requested actions Immediately report suspected monkeypox cases to Yakima County Health District. Call the reporting line at 800-535-5016 ext. 541. Consider submitting a suspect monkeypox intake form to help us determine whether to test for monkeypox. Be aware, recent confirmed cases of monkeypox in the United States differ from the classic monkeypox presentation of previous … 06/24/22 Health Advisory: Updated Monkeypox Guidance

05/05/22 Health Advisory: Colorado person first U.S. case of H5 bird flu

| May 5, 2022
Black triangle with ! "Health Advisory" on yellow background

A person in Colorado tested positive for avian influenza A(H5N1) virus (H5 bird flu), Colorado Department of Public Health and Environment reported April 28, 2022. Centers for Disease Control and Prevention (CDC) confirmed it is the first U.S. case of H5 bird flu. The person was involved in the culling of poultry with presumptive H5 … 05/05/22 Health Advisory: Colorado person first U.S. case of H5 bird flu

04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses eligibility for second booster dose of COVID-19 vaccine

| April 27, 2022
hands in blue medical gloves holding a syringe and drawing from a vile

Requested actions Be aware, on April 25, 2022, Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) advisory about the availability and use of recommended COVID-19 therapies. It also advised against using unproven treatments that have known or potential harm. Follow National Institutes of Health (NIH) COVID-19 treatment guidelines and use … 04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses eligibility for second booster dose of COVID-19 vaccine